医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

IntelliCentrics Launches Patient-Centric Visitor Management Transforming Healthcare Across China, North America, and the UK

2021年03月08日 AM10:30
このエントリーをはてなブックマークに追加


 

DALLAS

IntelliCentrics (6819.HK), the innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™ and now BioBytes™ Visitor, serves healthcare facilities across North America, the United Kingdom, and China, announces the creation of another industry first, BioBytes Visitor. BioBytes Visitor delivers value on two concurrent vectors by giving patients control over who can visit them when receiving care while providing locations of care (LOCs) with the ability to apply their safety and COVID-19 policies to visitors. The result is the first-ever technology platform to support the needs of every individual entering an LOC.

“The ability to trust patient visitors is uniquely important for three strategic reasons. Firstly, every year there are literally hundreds of millions of untrusted and unwelcome patient visitors entering our LOCs, compromising everyone’s safety and security. Secondly, COVID-19 taught us the most well-intended visits from family and friends can only happen with trust, at the right time and the right way. Thirdly, BioBytes Visitor is the ideal gateway for visitors to learn about our BioBytes telehealth solution which more deeply connects patients with family, friends and physicians,” said Michael Sheehan, CEO of IntelliCentrics.

IntelliCentrics’ Ethos is the first of its kind technology platform serving both the supply and demand sides of healthcare on a single, integrated, end-to-end technology platform. BioBytes delivers the portfolio of technologies serving the demand side of healthcare and integrates patients with their families and friends with the supply side of healthcare in a safe and trusted way.

“Each of our global markets continues to evolve, but they all demonstrate a large appetite for transformational healthcare technologies. By adding patient-centric visitor management to BioBytes, we believe that we can close the loop, offering a more deeply connected, trusted relationships in the healthcare journey,” continued Sheehan.

About IntelliCentrics
With a mission to use trust to make high-quality healthcare as accessible as a good cup of coffee, IntelliCentrics created the SEC³URE Ethos. Built on three core principles – transparency, neutrality, and independence, the SEC³URE Ethos is relied on by more than 11,000 locations of care worldwide to ensure mutual trust between patients, doctors, vendor representatives and healthcare companies. To learn more about the world’s largest trusted healthcare technology platform, visit www.intellicentrics.com. IntelliCentrics is publicly traded on The Stock Exchange of Hong Kong Limited under the stock code 6819.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210307005029/en/

CONTACT

Media Contact

Jennifer Xia

972-316-6523

jxia@intellicentrics.com

同じカテゴリーの記事 

  • NADclinic和Bontac Bio-Engineering (Shenzhen) Co., Ltd宣布建立战略合作伙伴关系,通过NAD+的力量开拓全球健康的未来
  • Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast
  • Brenmiller’s Project Pipeline Expands to 49 Projects Representing Over $500 Million in Potential Value in 12 Industries Across 13 Countries
  • NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+
  • Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients